N-terminal proatrial natriuretic peptide in primary care: Relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease

International Journal of Cardiology

Volumn 89, Issue 2-3, 2003, Pages 197-205

  Hall, Christian ^a   Ihlen, Halfdan ^a   Bonarjee, Vernon ^b   Dickstein, Kenneth ^b   Kjekshus, John ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Regionsykehuset i Rogaland   (Norway)

Author keywords

Atrial peptides; Heart failure congestive; Left; Ventricular function

Indexed keywords

N TERMINAL PROATRIAL NATRIURETIC PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; STRESS; SYMPTOM;

EID: 0037722782     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00479-5     Document Type: Article

References (32)

1. DeBold A.J., Borenstein H.B., Veress A.T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28:1981;89-94.
2. Dietz J.R. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol. 247:1984;R1093-R1096.
3. 126 is the storage form of rat atrial natriuretic factor. Biochem J. 241:1987;265-272.
4. Itoh H., Nakao K., Sugawara A., et al. Gamma-atrial natriuretic polypeptide (gammaANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alfa ANP. J Clin Endocrinol Metab. 67:1988;429-437.
5. Sundsfjord J.A., Thibault G., Larochelle P., Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab. 66:1988;605-610.
6. 2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides. 9:1988;47-53.
7. Hall C., Aaberge L., Stokke O. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation. 91:1995;911.
8. Richards A.M., Cleland J.G.F., Tonolo G., et al. Plasma alpha natriuretic peptide in cardiac impairment. Br Med J. 293:1986;409-412.
9. Mathisen P., Hall C., Simonsen S. Comparative study of atrial peptides ANF(1-98) and ANF(99-126) as diagnostic markers of atrial distension in patients with cardiac disease. Scand J Clin Lab Invest. 53:1993;41-49.
10. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:(1):1994;195-203.
11. Hall C., Kjekshus J., Eneroth P., Snapinn S. The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure. Clin Cardiol. 17:1994;191-195.
12. Hall C., Rouleau J.L., Moyè L., et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation. 89:1994;1934-1942.
13. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J. 16:1995;741-751.
14. Rossvoll O.E., Hatle L.K. Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol. 21:1993;1687-1696.
15. Ihlen H., Endresen K., Myreng Y., Myhre E. Reproducibility of cardiac stroke volume estimated by Doppler echocardiography. Am J Cardiol. 59:1987;975-978.
16. Myreng Y., Ihlen H. Reproducibility of transmitral flow parameters measured by pulsed Doppler echocardiography. J Cardiovasc Ultrason. 7:1988;257-261.
17. Steen T., Voss B.M.R., Ihlen H. Repeatability of measurements of pulmonary venous flow indices. Int J Cardiol. 47:1994;169-175.
18. Klein A.L., Burstow D.J., Tajik A.J., Zachariah P.K., Bailey K.R., Sweard J.B. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc. 69:1994;212-224.
19. Mizuno Y., Yoshimura M., Harada E., et al. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol. 86:2000;1036-1040.
20. Braunwald E. Heart disease. 5th ed:1997;379-380 W.B. Saunders, Philadelphia, PA.
21. Remes J., Miettinen H., Reunanen A., Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 12:1991;315-321.
22. Wheeldon N.M., MacDonald T.M., Flucker C.J., McKendrick A.D., McDevitt D.G., Struthers A.D. Echocardiography in chronic heart failure in the community. Q J Med. 86:1993;17-23.
23. Anderson J.V., Woodruff P.W., Bloom S.R. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Br Heart J. 59:1988;207-211.
24. Moe G.W., Rouleau J.L., Charbonneau L., et al. Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan. Am Heart J. 139:2000;587-595.
25. Pitt B. ACE inhibitor co-therapy in patients with heart failure: rationale for the randomized aldactone evaluation study (RALES). Eur Heart J. 16:(Suppl N):1995;107-110.
26. Remes J., Tikkanen I., Fyhrquist F., Pyörälä K. Neuroendocrine activity in untreated heart failure. Br Heart J. 65:1991;249-255.
27. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 350:1997;1347-1351.
28. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 351:1998;9-13.
29. Smith H., Pickering R.M., Struthers A., Simpson I., Mant D. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. Br Med J. 320:2000;906-908.
30. McClure S.J., Caruana L., Davie A.P., Goldthorp S., McMurray J.J.V. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. Br Med J. 317:1998;516-519.
31. Hetmanski D.J., Sparrow N.J., Curtis S., Cowley A.J. Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community. Heart. 84:2000;440-441.
32. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929.